The Association for Frontotemporal Degeneration (AFTD)
Amanda Gleixner is a Research Project Manager at The Association for Frontotemporal Degeneration (AFTD) since January 2023, focusing on scientific and logistical management to enhance FTD clinical trials and research. Prior experience includes serving as a Research Assistant Professor and Postdoctoral Associate at the University of Pittsburgh from December 2015 to January 2023, where research involved the nuclear pore complex and its role in nucleocytoplasmic trafficking. Amanda Gleixner completed a Ph.D. in Pharmacology at Duquesne University, where research centered on astrocyte adaptations in neurodegenerative diseases and held various teaching and leadership roles. Amanda also gained experience as a Graduate Assistant at the University at Buffalo and a Laboratory Technician at Saint Vincent College.
This person is not in any offices
The Association for Frontotemporal Degeneration (AFTD)
AFTD establish an institution dedicated to advancing FTD research, providing information, education, and support, as well as raising awareness of this uncommon and especially devastating disease, the AFTD, in whom mission is to improve the quality of life for those affected by FTD and drive research toward a cure, collaborated with a collective ofdedicated FTD care partners and medical professionals. With a committed board of directors, a robust volunteer network, and medical and scientific advisers from the leading experts from across the world, the company has developed into a major international structure on FTD and young onset dementia. AFTD has profited from kind foundation and donor funding, including gifts from the fund.